USRM OTC
U.S. Stem Cell, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -97.4%
5Y: -98.6%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$305K
+71.2% ▲
Capital Expenditures
$0
+0.0% ▲
Free Cash Flow
-$305K
+71.2% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$34K
-264.5% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$2M | -$4M | -$3M | -$3M | -$3M |
| Depreciation & Amort. | $207K | $243K | $0 | $0 | $0 |
| Stock-Based Comp. | $1M | $824K | $702K | $557K | $384K |
| Change in Working Capital | $637K | $97K | $141K | $28K | $285K |
| Other Non-Cash Items | $690K | $1M | $2M | $2M | $2M |
| Operating Cash Flow | $602K | -$1M | -$479K | -$1M | -$305K |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | $0 | $0 | $0 |
| Acquisitions (Net) | $312K | $167K | $0 | $0 | $0 |
| Investment Purchases | $190K | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | -$190K | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $312K | $167K | $0 | $0 | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | -$436K | -$428K | $148K | $714K | -$618 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$475K | $65K | $350K | $90K | $186K |
| Financing Cash Flow | -$544K | -$313K | $497K | $1M | $271K |
| Net Change in Cash | $370K | -$1M | $19K | $21K | -$34K |
| Cash End of Period | $1M | $0 | $19K | $39K | $5K |
| Free Cash Flow | $602K | -$1M | -$479K | -$1M | -$305K |